Evidence map›Paper›PMID 33516291›Full record

ArticleThe Lancet. Public health2021

Geographical and socioeconomic disparities in opioid access in Mexico, 2015-19: a retrospective analysis of surveillance data.

David Goodman-Meza, Joseph Friedman, Mariah M Kalmin, Emmanuel Aguilar-Posada, Marissa J Seamans, Sara Velazquez-Moreno, Clara Fleiz, Michael Shin, Jaime Arredondo-Sanchez, Steffanie A Strathdee and 1 more

Abstract read
In one paragraph

Article in The Lancet. Public health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

David Goodman-MezaDivision of Infectious Diseases, University of California, Los Angeles, CA, USA. Electronic address: dgoodman@mednet.ucla.edu.
Joseph FriedmanDavid Geffen School of Medicine, Center for Social Medicine and Humanities, University of California, Los Angeles, CA, USA.
Mariah M KalminDepartment of Family Medicine, University of California, Los Angeles, CA, USA.
Emmanuel Aguilar-PosadaDavid Geffen School of Medicine, Center for Social Medicine and Humanities, University of California, Los Angeles, CA, USA.
Marissa J SeamansDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, CA, USA.
Sara Velazquez-MorenoPrograma de Política de Drogas, Centro de Investigación y Docencia Económicas, Aguascalientes, Mexico.
Clara FleizDirección de Investigaciones Epidemiológicas y Psicosociales, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City, Mexico.
Michael ShinDepartment of Geography, University of California, Los Angeles, CA, USA.
Jaime Arredondo-SanchezPrograma de Política de Drogas, Centro de Investigación y Docencia Económicas, Aguascalientes, Mexico.
Steffanie A StrathdeeDepartment of Medicine, University of California San Diego, San Diego, CA, USA.
Steve ShoptawDepartment of Family Medicine, University of California, Los Angeles, CA, USA.

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Nina Thawata Harawa · 1997 to 2026
$53.5M
UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
Ethno-epidemiology of HCV, HIV and Overdose associated with Drug Marketsand Drug TourismR01DA049644 · NIDA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STRATHDEE, STEFFANIE A. · 2020 to 2024
$8.2M
Using data science to measure the impact of opioid agonist therapy in patients admitted with Staphylococcus aureus bloodstream infectionsK08DA048163 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GOODMAN, DAVID · 2019 to 2023
$1.0M
NIDA NIH HHS K08 DA048163NIDA NIH HHS R01 DA049644NIGMS NIH HHS T32 GM008042NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

backgroundIn 2015, Mexico implemented regulatory changes and an electronic system to improve access to prescription opioids. We aimed to investigate trends in opioid dispensing after the implementation of these changes and assess how opioid dispensing varied geographically and by socioeconomic status.

methodsIn this retrospective analysis of prescription medication surveillance data, we analysed dispensing data for group 1 medications (all opioids, including morphine, methadone, hydromorphone, oxycodone, tapentadol, fentanyl, sufentanil, and remifentanil) obtained from the Federal Commission for the Protection against Sanitary Risk database for 32 states and six large metropolitan areas in Mexico. We calculated crude annual opioid prescriptions per 10 000 people at the national, state, and municipal levels. Adapting methods from the report of the Lancet Commission on Palliative Care and Pain Relief, we calculated the need for palliative opioids by state, and then assessed the observed opioid dispensing rates as a percentage of expected need by geographical socioeconomic status. Within the six major metropolitan areas, we mapped the geocoded location of opioid prescriptions and assessed the association between opioid dispensing and socioeconomic status as well as the association between opioid dispensing and time to US border crossing for areas on the US-Mexico border.

findingsBetween June 25, 2015, and Oct 7, 2019, opioid dispensing rates increased by an average of 13% (95% CI 6·8-19·6) per quarter (3 months). The overall national opioid dispensing rate during the study period was 26·3 prescriptions per 10 000 inhabitants. States with a higher socioeconomic status had higher opioid dispensing rates than states with lower socioeconomic status (rate ratio [RR] 1·88, 95% CI 1·33-2·58, p=0·00016) after controlling for the estimated opioid requirement per state, the presence of methadone clinics, and the presence of tertiary hospitals and cancer centres. The same association between opioid dispensing and socioeconomic status was observed in the metropolitan areas, and in those metropolitan areas on the US-Mexico border a 20% decrease (RR 0·80, 95% CI 0·75-0·86) in opioid dispensation was observed per each SD increase (SD 17·1 min) in travel time to the border.

interpretationMeasures introduced by the Mexican federal Government to increase opioid access for patients with palliative care needs were only marginally successful in raising opioid prescription rates. Opioid access should be improved for patients with palliative care needs who live in geographical areas of lower socioeconomic status.

fundingUS National Institutes of Health.

Indexed as

Socioeconomic FactorsAnalgesics, OpioidDrug and Narcotic ControlHealth Services AccessibilityHealth Services Needs and DemandHumansMexicoPractice Patterns, Physicians'Retrospective StudiesSpatial AnalysisAnalgesics, Opioid

Identifiers

PMID33516291
PMCPMC7882061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.